HomeOwner SearchCategory Search
Visit USCOModulation of Integrin CD11b/CD18 as a Novel Therapeutic Strategy against Lung Cancer
Text Registration
Copyright Title
Modulation of Integrin CD11b/CD18 as a Novel Therapeutic Strategy against Lung Cancer
Status
Published
on 6 Feb 2020
Year of Creation
2019
Copyright Claimant
Terese Geraghty
Registration Number
TX0008847027
on 6 Feb 2020Copyright Summary
The U.S. Copyright record (Registration Number: TX0008847027) dated 6 Feb 2020, pertains to an electronic file (eService) titled "Modulation of Integrin CD11b/CD18 as a Novel Therapeutic Strategy against Lung Cancer" created in 2019. The copyright holder is Terese Geraghty, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Terese Geraghty.
Application Details
Registration Number
TX0008847027
Registration Date
2/6/2020
Year of Creation
2019
Agency Marc Code
DLC-CO
Record Status
New
Physical Description
Electronic file (eService)
First Publication Nation
United States
Notes
Rights Note: Mark Dill, ProQuest, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600, disspub@proquest.com
Statements
Application Title Statement: Modulation of Integrin CD11b/CD18 as a Novel Therapeutic Strategy against Lung Cancer
Author Statement: Terese Geraghty Citizenship: not known Authorship: text
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.